| |
|
|
|
|
|
|
|||
|
Blood, 1 May 2004, Vol. 103, No. 9, pp. 3320-3325. Prepublished online as a Blood First Edition Paper on December 30, 2003; DOI 10.1182/blood-2003-02-0352.
Submitted February 3, 2003
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan; Division of Clinical Gene Therapy, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan * Corresponding author; email: morishit{at}cgt.med.osaka-u.ac.jp.
In this study, we investigated the role of hepatocyte growth factor (HGF) in blood formation during Xenopus development. First, we examined the gene expression of HGF and its receptor, c-met, by whole-mount in situ hybridization during development. Strong signals of HGF as well as c-met were detected early in the developing ventral mesoderm which later gives rise to the ventral blood islands. Furthermore, to study the role of HGF, we blocked HGF signaling pathway in Xenopus embryos by using truncated c-met lacking the tyrosine kinase domain. Injection of truncated c-met mRNA resulted in a marked decrease in the number of circulating blood cells. Similar results were obtained using morpholino antisense HGF oligonucleotides. Moreover, we also analyzed the expression of several early primitive blood markers in the blood islands of these embryos. RNA in situ analysis revealed a significant reduction (or absence) of SCL,
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2003 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||